Session Three of Defeat Duchenne Canadian Conference Addressing Standards of Care in Canada to Take Place December 3rd and 4th

The NMD4C is proud to partner with Jesse’s Journey and Muscular Dystrophy Canada (MDC) in hosting the first national summit solely focused on DMD for health care providers across Canada, with the theme for this year’s event being ‘Addressing DMD Standards of Care in Canada’. We have brought together subject matter experts from pediatric and adult care for a comprehensive overview of the Canadian adaptation to the international DMD care considerations published in 2018.

Don’t forget to register for the third and final session of the CPD-accredited Defeat Duchenne Canadian Conference, which will take place on the 3rd and 4th of December, 2021 with sessions on Orthopedic Management and Rehabilitation Management in Duchenne on December 3rd, and Psychosocial Management and Duchenne and the Brain on December 4th.

Thank you to everyone from our community who completed the pre-event Canadian Duchenne standards of care survey. The results from the survey will be used as a springboard for discussion during the event and prepared for publication thereafter. We hope to see you at the conference!

Register for session three here!

 

 

Day 1: Friday, December 3, 2021

11 a.m. – 12:30 p.m. ET: Orthopedic Management in Duchenne

Moderator:

Co-Leads/Speakers:

  • Dr. Chris Reilly (Pediatric Orthopedic Surgeon)
  • Dr. Patricia Larouche (Pediatric Orthopedic Surgeon)

Learning Objectives:

  • Learn about the current landscape of Duchenne standards of care in orthopedic management across Canada.
  • Understand lived experience of orthopedic care from people with Duchenne and their families.
  • Participate in insightful discussion to identify and provide recommendations on how to address current gaps in Duchenne standards of care for orthopedic care.

 

12:30 – 2 p.m. ET: Rehabilitation Management in Duchenne

Moderator:

Co-Leads/Speakers:

  • Dr. Sue Dojeiji (Adult Physiatrist)
  • Dr. Jordan Sheriko (Medical Director of Pediatric Rehabilitation)

Speakers:

  • Dr. Anna McCormick (Pediatrician & Pediatric Physiatrist)
  • Charise MacDonald (Occupational Therapist)
  • Dr. Michael Berger (Adult Physiatrist)

Panelists:

  • Sarah Moore (Recreational Therapist)
  • Khalid Mahdi (DMD Adult)

Learning Objectives:

  • Learn about the current landscape of Duchenne standards of care in rehabilitation management.
  • Understand lived experience of rehabilitation services from people with Duchenne and their families.
  • Participate in insightful discussions to identify and provide recommendations on how to address current gaps in Duchenne standards of care in rehabilitation management.

 

Day 2: Saturday, December 4, 2021

11 a.m. – 12:30 p.m. ET: Duchenne and the Brain

Moderator/Lead:

Speakers:

  • Dr. Francesco Muntoni (Professor Pediatric Neurology) – Keynote Speaker
  • Dr. Veronica Hinton (Professor of Psychology)

Panelists:

  • Debra Chiabai (DMD Parent)

Learning Objectives:

  • Learn about the current landscape of Duchenne standards of care involving the brain across Canada.
  • Understand lived experience involving the brain from people with Duchenne and their families.
  • Participate in insightful discussion to identify and provide recommendations on how to address current gaps in Duchenne standards of care involving the brain.

 

12:30 – 2 p.m. ET: Psychosocial Management

Moderator:

Co-Leads/Speakers:

  • Dr. Jean Mah (Pediatric Neurologist)
  • Dr. Stephanie Plamondon (Adult Physiatrist)

Panelist:

  • Debra Chiabai (DMD Parent)
  • Zoe Schwartz (Pediatric Social Worker)

Learning Objectives:

  • Learn about the current landscape of Duchenne standards of care in psychosocial management across Canada.
  • Understand lived experience of psychosocial management from people with Duchenne and their families.
  • Participate in insightful discussion to identify and provide recommendations on how to address current gaps in Duchenne standards of care for psychosocial management.
DDCC21_speakers_poster

Read next...

04-2026 - NMD4C Investigators Awarded $5.7 Million as Part of National Team to Advance 3D Models for Brain and Neuromuscular Research - OHRI

NMD4C Investigators Awarded $5.7 Million as Part of National Team to Advance 3D Models for Brain and Neuromuscular Research

NMD4C investigators are part of a national research team awarded $5.7 million in Canada Foundation for Innovation (CFI) infrastructure funding to support the development of advanced 3D human tissue models for brain and neuromuscular research. The initiative brings together researchers from The Ottawa Hospital, the University of Ottawa, and the University of Toronto, and is co‑led by NMD4C investigator Dr. Michael Rudnicki, alongside Dr. Penney Gilbert and Dr. Mireille Khacho. This shared infrastructure will enable cutting‑edge neuromuscular and neural tissue research, accelerate discovery, and provide hands‑on training opportunities for trainees across Canada.

2027 NMD4C-MDC Clinical Neuromuscular Fellowship Competition

Sixth Annual NMD4C and MDC Clinical Fellowship Competition from Opens May 1st

Together, NMD4C and MDC are excited to open our 2027 annual funding competition to provide clinical fellowship award(s) in neuromuscular medicine and electromyography (EMG)!  This annual funding competition provides one-year salary support ($80,000) for early-career clinicians to participate in Canadian neuromuscular medicine and EMG fellowship training programs.

04-2026 - Advancing Neuromuscular Research_ MDC Awards $700k to Seven NMD4C Investigator-Led Projects

Advancing Neuromuscular Research: MDC Awards $700k to Seven NMD4C Investigator-Led Projects

We’re proud to share that neuromuscular research led by our NMD4C Investigators and Leads; Dr. Hanns Lochmüller, Dr. Rashmi Kothary, Dr. Rami Massie, Dr. Elise Duchesne, Dr. Omid Kiamanesh, and Dr. Nicolas Dumont,  have been recognized in Muscular Dystrophy Canada’s 2026 Neuromuscular Clinical and Translational Research Grant announcement. Drawing from MDC’s national funding update, we’re…